CNC / Centene Corporation (NYSE) - Forecast, Price Target, Estimates, Predictions

Centene Corporation
US ˙ NYSE ˙ US15135B1017

Projected Stock Price
$37.01 ↑27.76%

Estimated share price by September 3, 2026.

Projected Revenue

43,233  MM ↑0.92%

Estimated quarterly revenue by December 31, 2026.

Projected Earnings Per Share

1.27 ↑347.27%

Estimated quarterly earnings by December 31, 2027.

Price Target

The average one-year price target for Centene Corporation is $37.01. The forecasts range from a low of $24.24 to a high of $96.08.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-09-03 2026-09-03 96.08 24.24 31.11 37.01
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Centene Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Why Are Analyst Ratings important?

In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.

Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.

If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?

You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.

How to Use Analyst Ratings ?

Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.

Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.

Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.

How are the Fintel Analyst Ratings different?

Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.

Date Analyst Prior Latest
Recommendation
Action
2022-12-19 Credit Suisse Outperform Maintains
2022-12-13 B of A Securities Neutral Underperform Downgrade
2022-10-03 Barclays Overweight Maintains
2022-09-30 Argus Research Buy Initiate
2022-08-26 Wells Fargo Overweight Equal-Weight Downgrade
2022-07-28 Barclays Overweight Reiterate
2022-07-27 Mizuho Neutral Maintains
2022-07-27 Credit Suisse Outperform Maintains
2022-07-14 Truist Securities Buy Maintains
2022-07-14 Jefferies Hold Buy Upgrade
2022-06-23 Morgan Stanley Overweight Maintains
2022-06-22 Deutsche Bank Buy Maintains
2022-06-21 Credit Suisse Neutral Outperform Upgrade
2022-06-17 Loop Capital Buy Initiate
2022-05-27 Bernstein Outperform Reiterate
2022-05-26 B of A Securities Buy Neutral Downgrade
2022-05-25 Wells Fargo Overweight Maintains
2022-04-27 Morgan Stanley Overweight Maintains
2022-02-09 Mizuho Neutral Maintains
2022-02-09 Deutsche Bank Buy Maintains
2022-01-07 Barclays Overweight Reiterate
2021-12-17 Morgan Stanley Overweight Maintains
2021-12-14 Goldman Sachs Neutral Initiate
2021-12-13 Wells Fargo Overweight Maintains
2021-12-13 Oppenheimer Outperform Maintains
2021-12-13 Credit Suisse Neutral Maintains
2021-12-13 BMO Capital Outperform Maintains
2021-10-27 Morgan Stanley Overweight Maintains
2021-10-27 Credit Suisse Neutral Maintains
2021-09-14 Morgan Stanley Overweight Maintains
2021-09-14 Credit Suisse Neutral Maintains
2021-08-31 Morgan Stanley Overweight Maintains
2021-08-03 Wells Fargo Overweight Maintains
2021-07-09 Seaport Global Buy Initiate
2021-06-17 Wells Fargo Overweight Maintains
2021-06-17 Truist Securities Buy Maintains
2021-06-17 Mizuho Neutral Maintains
2021-06-17 Citigroup Buy Maintains
2021-06-17 BMO Capital Outperform Maintains
2021-06-08 B of A Securities Buy Maintains
2021-05-19 Wells Fargo Overweight Initiate
2021-05-11 Stephens & Co. Equal-Weight Overweight Upgrade
2021-05-11 BMO Capital Outperform Maintains
2021-03-10 Mizuho Neutral Initiate
2021-01-15 Jefferies Buy Hold Downgrade
2020-12-14 SVB Leerink Outperform Maintains
2020-10-28 SVB Leerink Outperform Maintains
2020-10-28 Credit Suisse Neutral Maintains
2020-07-29 Jefferies Buy Maintains
2020-07-01 SVB Leerink Outperform Initiate
2020-04-29 Oppenheimer Outperform Maintains
2020-04-29 Deutsche Bank Buy Maintains
2020-04-29 Citigroup Buy Maintains
2020-04-13 SunTrust Robinson Humphrey Buy Maintains
2020-04-13 Morgan Stanley Overweight Maintains
2020-03-27 Morgan Stanley Overweight Maintains
2020-03-06 Deutsche Bank Buy Maintains
2020-02-18 Deutsche Bank Buy Maintains
2020-02-05 JP Morgan Overweight Initiate
2020-02-05 Credit Suisse Neutral Maintains
2020-02-05 Citigroup Buy Maintains
2020-01-24 Wells Fargo Overweight Maintains
2020-01-08 Credit Suisse Neutral Maintains
2020-01-06 Wolfe Research Peer Perform Outperform Upgrade
2019-12-16 BMO Capital Outperform Maintains
2019-11-22 Morgan Stanley Overweight Maintains
2019-11-18 SunTrust Robinson Humphrey Buy Maintains
2019-10-23 Deutsche Bank Buy Maintains
2019-10-23 Credit Suisse Neutral Maintains
2019-09-26 Morgan Stanley Overweight Maintains
2019-09-12 Deutsche Bank Buy Initiate
2019-08-23 Morgan Stanley Overweight Maintains
2019-07-12 Morgan Stanley Overweight Maintains
2019-05-10 Citigroup Neutral Buy Upgrade
2019-04-24 Morgan Stanley Overweight Overweight Maintains
2019-03-29 Credit Suisse Neutral Neutral Maintains
2019-02-28 Cowen & Co. Outperform Initiate
2019-01-14 Stephens & Co. Overweight Initiate
2018-12-17 Cantor Fitzgerald Overweight Overweight Maintains
2018-10-24 Leerink Swann Market Perform Outperform Upgrade
2018-10-02 Oppenheimer Outperform Outperform Maintains
2018-09-19 Mitsubishi UFJ Overweight Initiate
2018-09-05 Morgan Stanley Overweight Overweight Maintains
2018-07-25 Morgan Stanley Overweight Overweight Maintains
2018-07-25 Credit Suisse Neutral Neutral Maintains
2018-07-25 Cantor Fitzgerald Overweight Overweight Maintains
2018-07-24 Bank of America Buy Buy Maintains
2018-07-23 Barclays Overweight Initiate
2018-07-13 Morgan Stanley Overweight Overweight Maintains
2018-06-18 Credit Suisse Neutral Neutral Maintains
2018-04-25 Morgan Stanley Overweight Overweight Maintains
2018-02-13 Leerink Swann Market Perform Market Perform Maintains
2018-02-07 Morgan Stanley Overweight Overweight Maintains
2018-02-07 Credit Suisse Neutral Neutral Maintains
2018-02-07 Cantor Fitzgerald Buy Overweight Maintains
2018-01-03 Goldman Sachs Buy Initiate
2017-11-02 Credit Suisse Neutral Initiate
2017-10-25 Oppenheimer Outperform Maintains
2017-10-17 BMO Capital Outperform Initiate
2017-10-13 Jefferies Buy Maintains
2017-09-21 Morgan Stanley Overweight Maintains
2017-07-26 UBS Buy Maintains
2017-07-26 Morgan Stanley Overweight Maintains
2017-07-26 Citigroup Sell Maintains
2017-07-14 Bank of America Buy Maintains
2017-07-13 Deutsche Bank Buy Maintains
2017-06-07 Morgan Stanley Overweight Initiate
2017-05-22 JP Morgan Overweight Neutral Downgrade
2017-04-05 Deutsche Bank Buy Initiate
2017-01-04 PiperJaffray Overweight Initiate
2016-12-21 JP Morgan Overweight Initiate
2016-12-13 Goldman Sachs Sell Neutral Upgrade
2016-11-14 Bernstein Market Perform Outperform Upgrade
2016-11-11 Credit Suisse Outperform Neutral Downgrade
2016-10-05 Credit Suisse Outperform Maintains
2016-09-23 Evercore ISI Group Buy Initiate
2016-09-06 Leerink Swann Outperform Market Perform Downgrade
2016-07-27 Jefferies Buy Maintains
2016-06-29 Morgan Stanley Equal-Weight Overweight Upgrade
2016-06-20 Barclays Equal-Weight Overweight Upgrade
2016-06-16 Bernstein Market Perform Initiate
2016-05-26 Stifel Nicolaus Hold Buy Upgrade
2016-04-25 Cowen & Co. Outperform Initiate
2016-02-10 Barclays Equal-Weight Maintains
2016-01-08 Jefferies Buy Maintains
2016-01-06 Barclays Equal-Weight Maintains
2015-12-21 Leerink Swann Outperform Maintains
2015-12-21 Jefferies Buy Maintains
2015-12-16 Credit Suisse Outperform Initiate
2015-07-27 UBS Neutral Buy Upgrade
2015-07-21 Goldman Sachs Neutral Sell Downgrade
2015-07-15 Jefferies Hold Buy Upgrade
2015-07-13 FBR Capital Market Perform Outperform Upgrade
2015-07-08 Wells Fargo Market Perform Outperform Upgrade
2015-07-06 Barclays Overweight Equal-Weight Downgrade
2015-06-22 Oppenheimer Outperform Maintains
2015-06-15 Susquehanna Positive Maintains
2015-06-15 Leerink Swann Outperform Maintains
2015-06-15 Jefferies Hold Maintains
2015-06-15 Deutsche Bank Hold Maintains
2015-06-15 Cantor Fitzgerald Buy Maintains
2015-06-15 Barclays Overweight Maintains
2015-04-29 Jefferies Hold Maintains
2015-04-29 Cantor Fitzgerald Buy Maintains
2015-04-16 Oppenheimer Outperform Maintains
2015-03-20 Barclays Overweight Maintains
2015-02-24 Barclays Overweight Maintains
2015-02-04 Deutsche Bank Hold Maintains
2015-01-08 Barclays Overweight Maintains
2015-01-06 Deutsche Bank Hold Maintains
2015-01-06 BMO Capital Market Perform Outperform Upgrade
2014-12-18 Citigroup Sell Maintains
2014-12-16 Credit Suisse Outperform Maintains
2014-12-15 Jefferies Hold Maintains
2014-12-15 Barclays Overweight Maintains
2014-12-15 Bank of America Buy Maintains
2014-11-18 Bank of America Buy Maintains
2014-11-13 FBR Capital Outperform Market Perform Downgrade
2014-11-12 Oppenheimer Outperform Maintains
2014-10-30 Credit Suisse Outperform Maintains
2014-10-29 Deutsche Bank Hold Maintains
2014-10-29 Barclays Overweight Maintains
2014-10-28 Citigroup Sell Maintains
2014-10-28 Barclays Overweight Maintains
2014-07-29 JP Morgan Neutral Maintains
2014-07-25 Wells Fargo Market Perform Downgrade
2014-07-25 Citigroup Sell Maintains
2014-07-23 FBR Capital Outperform Maintains
2014-07-23 Deutsche Bank Hold Maintains
2014-07-23 Citigroup Outperform Maintains
2014-07-23 Barclays Overweight Maintains
2014-07-16 Deutsche Bank Hold Maintains
2014-06-27 Sterne Agee Buy Initiate
2014-06-26 Oppenheimer Outperform Maintains
2014-06-16 UBS Neutral Maintains
2014-06-16 Oppenheimer Outperform Maintains
2014-06-16 JP Morgan Neutral Maintains
2014-06-16 Credit Suisse Outperform Maintains
2014-06-03 Citigroup Neutral Sell Downgrade
2014-05-19 FBR Capital Outperform Maintains
2014-04-25 Cantor Fitzgerald Buy Maintains
2014-04-23 Leerink Swann Outperform Maintains
2014-04-23 Deutsche Bank Hold Maintains
2014-04-23 Citigroup Hold Maintains
2014-04-16 UBS Neutral Initiate
2014-02-05 Citigroup Sell Neutral Upgrade
2014-01-23 Credit Suisse Neutral Outperform Upgrade
2014-01-22 Credit Suisse Neutral Outperform Upgrade
2013-12-16 Susquehanna Neutral Positive Upgrade
2013-12-16 Deutsche Bank Hold Maintains
2013-11-20 Morgan Stanley Equal-Weight Initiate
2013-11-19 Leerink Swann Outperform Initiate
2013-11-13 FBR Capital Outperform Initiate
2013-10-23 Monness Crespi Hardt Buy Neutral Downgrade
2013-10-23 Jefferies Hold Maintains
2013-10-23 Citigroup Neutral Sell Downgrade
2013-10-08 Deutsche Bank Hold Maintains
2013-09-16 Jefferies Hold Maintains
2013-07-24 Oppenheimer Outperform Maintains
2013-07-24 Jefferies Hold Maintains
2013-07-23 Monness Crespi Hardt Buy Maintains
2013-07-23 Cantor Fitzgerald Hold Buy Upgrade
2013-07-16 Deutsche Bank Hold Maintains
2013-06-27 Lazard Buy Initiate
2013-06-18 Jefferies Hold Maintains
2013-06-18 BMO Capital Market Perform Maintains
2013-05-30 Monness Crespi Hardt Buy Maintains
2013-05-24 Raymond James Outperform Market Perform Downgrade
2013-04-24 Jefferies Hold Maintains
2013-04-24 Citigroup Neutral Maintains
2013-04-23 Deutsche Bank Hold Maintains
2013-04-17 Deutsche Bank Hold Maintains
2013-04-11 Bank of America Buy Maintains
2013-04-02 Deutsche Bank Hold Maintains
2013-03-14 JP Morgan Overweight Neutral Downgrade
2013-02-06 Jefferies Hold Maintains
2013-02-06 Citigroup Buy Neutral Downgrade
2013-02-06 BMO Capital Market Perform Maintains
2012-12-18 Jefferies Buy Hold Downgrade
2012-12-04 Monness Crespi Hardt Buy Maintains
2012-11-07 Bank of America Underperform Buy Upgrade
2012-10-24 Jefferies Buy Maintains
2012-10-23 Deutsche Bank Hold Maintains
2012-10-18 Deutsche Bank Hold Maintains
2012-10-15 Deutsche Bank Hold Maintains
2012-07-25 Jefferies Buy Maintains
2012-07-25 Deutsche Bank Hold Maintains
2012-07-25 Barclays Overweight Maintains
2012-07-23 JP Morgan Overweight Maintains
2012-07-23 Bank of America Neutral Underperform Downgrade
2012-07-18 Deutsche Bank Hold Maintains
2012-05-11 Morgan Stanley Underweight Maintains
2012-05-10 Cantor Fitzgerald Buy Maintains
2012-04-17 Jefferies Buy Maintains
2012-04-10 BMO Capital Market Perform Maintains
2012-03-30 Jefferies Buy Initiate
2012-02-08 Oppenheimer Outperform Maintains
2023-01-06 JP Morgan Overweight Maintains
2023-02-08 Goldman Sachs Neutral Maintains
2023-02-08 Mizuho Neutral Maintains
2023-02-08 JP Morgan Overweight Maintains
2023-02-08 Barclays Overweight Maintains
2023-02-09 Goldman Sachs Neutral Maintains
2023-02-14 Cowen & Co. Outperform Maintains
2023-02-28 Mizuho Neutral Maintains
2023-02-23 JP Morgan Overweight Neutral Downgrade
2023-03-09 Morgan Stanley Overweight Maintains
2023-03-08 Deutsche Bank Buy Hold Downgrade
2023-03-21 Wells Fargo Equal-Weight Maintains
2023-05-26 Stephens & Co. Overweight Overweight Reiterate
2023-05-26 Oppenheimer Outperform Outperform Reiterate
2023-04-11 Barclays Overweight Maintains
2023-04-21 Cantor Fitzgerald Overweight Initiate
2023-04-26 Credit Suisse Outperform Maintains
2023-04-26 Barclays Overweight Maintains
2023-04-26 Truist Securities Buy Maintains
2023-04-26 Stephens & Co. Overweight Maintains
2023-07-12 Wolfe Research Outperform Peer Perform Downgrade
2023-06-20 Truist Securities Buy Buy Maintains
2023-06-20 UBS Neutral Initiate
2023-09-05 B of A Securities Underperform Neutral Upgrade
2024-03-25 Stephens & Co. Overweight Equal-Weight Downgrade
2023-07-31 Oppenheimer Outperform Outperform Reiterate
2023-07-31 Barclays Overweight Overweight Maintains
2023-08-30 Morgan Stanley Overweight Equal-Weight Downgrade
2023-12-13 Wells Fargo Equal-Weight Equal-Weight Maintains
2023-07-11 Mizuho Neutral Neutral Maintains
2023-07-07 JP Morgan Neutral Neutral Maintains
2023-09-14 Cantor Fitzgerald Overweight Overweight Reiterate
2023-10-26 Wells Fargo Equal-Weight Equal-Weight Maintains
2023-10-09 Jefferies Buy Buy Maintains
2023-07-14 Morgan Stanley Overweight Overweight Reiterate
2023-12-21 UBS Neutral Neutral Maintains
2023-12-21 Truist Securities Buy Buy Maintains
2024-05-30 Stephens & Co. Equal-Weight Equal-Weight Reiterate
2023-12-15 Cantor Fitzgerald Overweight Overweight Maintains
2024-01-02 Wells Fargo Equal-Weight Overweight Upgrade
2023-11-21 Cantor Fitzgerald Overweight Overweight Reiterate
2024-03-20 Wells Fargo Overweight Overweight Maintains
2024-05-02 Barclays Overweight Overweight Maintains
2024-04-04 Cantor Fitzgerald Overweight Overweight Reiterate
2024-04-15 Wells Fargo Overweight Overweight Maintains
2024-03-06 Barclays Overweight Initiate
2024-05-30 Baird Neutral Initiate
2024-04-30 Deutsche Bank Hold Hold Maintains
2024-04-08 Wells Fargo Overweight Overweight Maintains
2024-04-29 Oppenheimer Outperform Outperform Maintains
2024-03-21 Stephens & Co. Overweight Equal-Weight Downgrade
2024-06-12 Cantor Fitzgerald Overweight Overweight Reiterate
2024-07-11 Jefferies Buy Buy Maintains
2024-07-10 JP Morgan Neutral Neutral Maintains
2024-07-15 Truist Securities Buy Buy Maintains
2024-06-21 Oppenheimer Outperform Outperform Reiterate
2024-09-13 Wells Fargo Overweight Overweight Maintains
2024-08-05 Stephens & Co. Equal-Weight Equal-Weight Reiterate
2024-10-29 Barclays Overweight Overweight Maintains
2025-04-29 Guggenheim Neutral Neutral Reiterate
2024-07-24 TD Cowen Buy Buy Maintains
2024-07-24 Jefferies Buy Hold Downgrade
2025-04-29 Jefferies Hold Hold Maintains
2024-09-10 Cantor Fitzgerald Overweight Overweight Reiterate
2024-09-20 Cantor Fitzgerald Overweight Overweight Reiterate
2024-10-25 Baird Neutral Neutral Maintains
2024-07-22 Wells Fargo Overweight Overweight Maintains
2024-08-02 Deutsche Bank Hold Hold Maintains
2024-12-13 UBS Neutral Buy Upgrade
2024-08-22 Barclays Overweight Overweight Maintains
2025-04-15 Baird Neutral Neutral Maintains
2024-10-30 Bernstein Outperform Outperform Maintains
2024-12-13 Barclays Overweight Overweight Maintains
2024-12-13 Truist Securities Buy Buy Maintains
2024-12-13 Stephens & Co. Equal-Weight Equal-Weight Maintains
2024-12-13 Oppenheimer Outperform Outperform Maintains
2024-08-19 Cantor Fitzgerald Overweight Overweight Reiterate
2024-07-29 Oppenheimer Outperform Outperform Maintains
2024-07-31 TD Cowen Buy Buy Maintains
2024-08-05 Wells Fargo Overweight Overweight Maintains
2024-07-23 Cantor Fitzgerald Overweight Overweight Reiterate
2025-02-14 Wells Fargo Overweight Overweight Maintains
2024-12-10 Jefferies Hold Underperform Downgrade
2025-04-08 Jefferies Underperform Hold Upgrade
2024-09-05 Barclays Overweight Overweight Maintains
2024-10-01 Cantor Fitzgerald Overweight Overweight Reiterate
2024-11-04 Wells Fargo Overweight Overweight Maintains
2025-07-16 Truist Securities Buy Buy Maintains
2024-12-11 Cantor Fitzgerald Overweight Overweight Reiterate
2025-04-09 Guggenheim Neutral Initiate
2025-07-10 Morgan Stanley Overweight Equal-Weight Downgrade
2025-04-28 Barclays Overweight Overweight Maintains
2025-07-25 Baird Neutral Neutral Maintains
2025-09-04 Barclays Equal-Weight Equal-Weight Maintains
2025-06-09 Morgan Stanley Overweight Initiate
2025-07-11 Mizuho Neutral Neutral Maintains
2025-06-02 Barclays Overweight Equal-Weight Downgrade
2025-07-28 Cantor Fitzgerald Overweight Neutral Downgrade
2025-07-02 Cantor Fitzgerald Overweight Overweight Maintains
2025-07-02 B of A Securities Neutral Neutral Maintains
2025-07-02 Barclays Equal-Weight Equal-Weight Maintains
2025-07-02 UBS Buy Neutral Downgrade
2025-07-02 JP Morgan Overweight Neutral Downgrade
2025-07-21 TD Cowen Buy Hold Downgrade
2025-08-04 Morgan Stanley Equal-Weight Equal-Weight Maintains
2025-07-16 B of A Securities Neutral Underperform Downgrade
2025-07-23 Wells Fargo Overweight Equal-Weight Downgrade
2025-07-28 Oppenheimer Outperform Outperform Maintains
2025-07-28 Truist Securities Buy Buy Maintains
2025-07-28 UBS Neutral Neutral Maintains
2025-09-05 Bernstein Outperform Outperform Maintains
2025-07-15 Oppenheimer Outperform Outperform Maintains
2025-08-26 Cantor Fitzgerald Neutral Neutral Reiterate
2025-07-29 JP Morgan Neutral Neutral Maintains
Revenue Estimates

The forecasted annual revenue of Centene Corporation in 2031-12-31 is 210,935MM. )

Understanding a company’s revenue history gives investors a snapshot of its potential growth. Revenue growth is a solid predictor of earnings (or profit) growth. A company that can increase its revenue while keeping its operating costs constant has more available capital to reinvest into its business or return to shareholders through dividends or share buybacks.

However, investors should be careful before investing in a company that is growing revenue but showing declining earnings or is unprofitable. In some cases, this is simply a case of a young company that is still in an early growth phase. But if this is a mature company, it can indicate that other fundamental problems exist.

How to Interpret Revenue Estimates?

Fintel gives you revenue projections for stocks that cover 10 years between 2020 and 2030. Although past performance does not guarantee future results, you can be more confident in your decision to buy or sell a stock when you see a company with revenue that has a track record of increasing its revenue.

Update Frequency: Quarterly

Date Revenue Average Quarterly (MM) Number of Analysts (Quarterly) Revenue Average Annually (MM) Number of Analysts (Annually)
2025-09-30 36,714 2 -- --
2025-12-31 36,344 2 150,025 6
2026-03-31 40,965 3 -- --
2026-06-30 39,763 3 -- --
2026-09-30 41,140 3 -- --
2026-12-31 43,233 3 152,728 3
2027-12-31 -- -- 162,189 3
2028-12-31 -- -- 165,605 2
2029-12-31 -- -- 173,002 2
2030-12-31 -- -- 207,767 2
2031-12-31 -- -- 210,935 2
Earnings Estimates

The forecasted annual earnings of Centene Corporation in 2032-12-31 is 16.60 per share.

One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).

Earnings per Share Calculation

To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).

The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:

Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:

100,000,000/40,000,000 = $2.50 per share

How to use Earnings Per Share in Stock Analysis

Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.

However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.

You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.

Update Frequency: Quarterly

Date EPS Average (Quarterly) Number of Analysts (Quarterly) EPS Average (Annual) Number of Analysts (Annually)
2025-09-30 1.98 2 -- --
2025-12-31 1.33 3 8.36 13
2026-03-31 2.68 3 -- --
2026-06-30 2.74 3 -- --
2026-09-30 2.07 3 -- --
2026-12-31 1.08 3 9.48 13
2027-03-31 2.83 3 -- --
2027-06-30 2.70 3 -- --
2027-09-30 2.29 3 -- --
2027-12-31 1.27 3 10.73 3
2028-12-31 -- -- 10.94 2
2029-12-31 -- -- 12.24 2
2030-12-31 -- -- 12.48 2
2031-12-31 -- -- 15.06 2
2032-12-31 -- -- 16.60 2
EBITDA Estimates

The forecasted annual EBITDA of Centene Corporation in 2026-12-31 is 6,701MM.

EBIDTA is an acronym that stands for earnings before interest, taxes, depreciation, and amortization. Analysts and investors pay attention to EBITDA because it strips out items that a company must report on its balance sheet but doesn’t significantly impact its business. Here’s an explanation of what that means for each part of the acronym:

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

EBITDA vs. Net Income

Net income is the profit a company has left over after covering its operating expenses. However, net income includes the items that EBITDA excludes. That’s why most analysts prefer EBITDA because it better reflects the health of a company’s core business.

Update Frequency: Quarterly

Date EBITDA Average (MM Quarterly) Number of Analysts (Quarterly) EBITDA Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2026-06-30
2026-09-30
2026-12-31
EBIT Estimates

The forecasted annual EBIT of Centene Corporation in 2026-12-31 is 5,672MM.

EBIT is an acronym that stands for earnings before interest and taxes. Analysts use EBIT to measure a company’s performance because it strips out tax expenses and the costs of the capital structure influencing profit. These don’t significantly impact a company’s business.

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

NOTE: EBIT is sometimes synonymous with operating income. However, in some cases, operating income doesn’t include gains or losses from non-core activities.

EBIT vs. EBITDA

EBITDA also strips out depreciation and amortization from a company’s earnings:

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

Update Frequency: Quarterly

Date EBIT Average (MM Quarterly) Number of Analysts (Quarterly) EBIT Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2026-06-30
2026-09-30
2026-12-31
Other Listings
IT:1CNC €24.45
MX:CNC
GB:0HVB $28.84
DE:QEN €24.68
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista